Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia

October 25, 2022 updated by: Shanghai Mental Health Center

Discussion on the Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia Based on the Theory of "Heart Dominating Mind" and "Body-spirit Syncretism" in Traditional Chinese Medicine

The purpose of this study is to observe the intervention effect of shen-based Qigong exercise on residual symptoms of schizophrenia.

Study Overview

Detailed Description

Shen-based Qigong exercise is a new kind of health-care Qigong exercise based on the theory of traditional Chinese medicine, aiming at the characteristics of schizophrenia. In this study, a randomized controlled trial was conducted to observe the rehabilitation effect of this new exercise on residual symptoms of schizophrenic patients. Questionnaire, test and other experimental materials were used to evaluate the intervention effect of 12-week shen-based Qigong exercise on psychiatric symptoms, cognitive function, quality of life and social function of schizophrenic patients. At the same time, the related physical function and cardiac function indexes were used to evaluate the physical and cardiac rehabilitation effects of the exercise on patients from the aspects of "body" and "heart", so as to verify whether Qigong exercise has the effects of adjusting body and heart.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200030
        • Recruiting
        • Shanghai Mental Health Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Han Chinese population
  2. age ≥ 18 years
  3. education level ≥ 6 years, can fill in the questionnaire independently, have enough audio-visual level to complete the necessary examination
  4. assessed by MINI 7.0 and satisfied with the diagnostic criteria for schizophrenia based on the Diagnostic and Statistical Manual of Mental Disorders, fifth edition(DSM-5)
  5. patients with schizophrenia residing in the rehabilitation ward, without relapse in the past 6 months
  6. residual negative symptoms, with at least one item ≥ 2 on the negative subscale of PANSS (N1-N7)
  7. taking second generation antipsychotics
  8. no training history of traditional Chinese exercises
  9. agreement to participate in the study and willing to give written informed consent

Exclusion Criteria:

  1. having severe physical diseases such as cardiovascular, lung, liver, kidney, and hematopoietic diseases
  2. satisfied with the diagnostic criteria for other mental disorders based on DSM-5
  3. having alcohol or substance abuse/dependence
  4. having mental retardation(WAIS<70) and/or severe cognitive impairment(MMSE<24)
  5. having visual and / or hearing problems, unable to complete the relevant test
  6. electroconvulsive or repetitive transcranial magnetic stimulation(rTMS) therapy in the past 3 months
  7. currently enrolled or participated in other clinical studies in the past 3 months
  8. participating in regular exercise training in the past 6 months
  9. failure to sign or refuse to sign informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control group
daily rehabilitation interventions
including Naikan therapy, Morita therapy, group art therapy, group painting therapy
Experimental: Interventional group
daily rehabilitation interventions and shen-based Qigong exercise
including Naikan therapy, Morita therapy, group art therapy, group painting therapy
a 12-week intervention of shen-based Qigong exercise : exercise 5 days a week, about 30 minutes a day

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of the Scale for the Assessment of Negative Symptoms (SANS)
Time Frame: Change from Baseline at 3 months
Negative symptoms will be evaluated using the Scale for the Assessment of Negative Symptoms (SANS). The scale made up for the lack of attention to negative symptoms in previous psychiatric rating scales. It contains five subscales: affective blunting, alogia, avolition/apathy, anhedonia/asociality, and attention. A total of 24 items were scored at 6 levels for each item.
Change from Baseline at 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Time Frame: Change from Baseline at 3 months
RBANS will be used to assess global cognitive function. RBANS yields scaled scores for 5 cognitive domains and shows a good effect in cognitive assessment of patients with schizophrenia.
Change from Baseline at 3 months
change of event-related potential P300 (ERP P300)
Time Frame: Change from Baseline at 3 months
ERP P300 will be used to assess global cognitive function. ERP P300 is an endogenous cognitive component related to high-level psychological activities such as attention, memory, feeling, learning and reasoning. It has good stability and can reflect the level of cognitive function from different aspects.
Change from Baseline at 3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of n-back task
Time Frame: Change from Baseline at 3 months
Specific cognitive domain--working memory will be assessed by n-back task. N-back task paradigm is the most classical paradigm in working memory research.
Change from Baseline at 3 months
change of 36-item Short Form Health Survey(SF-36)
Time Frame: Change from Baseline at 3 months
36-item Short Form Health Survey(SF-36)will be used to assess the health-related quality of life of patients. SF-36 is one of the most commonly used standardized measurement tools for quality of life in the world, including eight subscales, a total of 36 items, involving physical and mental health.
Change from Baseline at 3 months
change of Social-Adaptive Functioning Evaluation (SAFE)
Time Frame: Change from Baseline at 3 months
Social functions will be assessed using Social-Adaptive Functioning Evaluation (SAFE). SAFE can evaluate the social adaptation function of patients with mental disorders over 18 years old. It has a total of 19 items, divided into basic life skills, advanced life skills, social skills and communication skills in four areas; each item 0-4 score, the higher the score, the more serious the damage.
Change from Baseline at 3 months
change of the Scale for the Assessment of Positive Symptoms (SAPS)
Time Frame: Change from Baseline at 3 months
Positive symptoms will be evaluated using the Scale for the Assessment of Positive Symptoms (SAPS). SAPS measures positive symptoms on a 34 item, 6-point scale, a total of 170 points. Items are listed under hallucinations, delusions, bizarre behavior, and positive formal thought disorder.
Change from Baseline at 3 months
change of heart rate variability (HRV)
Time Frame: Change from Baseline at 3 months
Heart rate variability (HRV) will be used as the evaluation index for cardiac function. HRV is a widely used non-invasive tool for evaluating cardiac autonomic nerve function.
Change from Baseline at 3 months
change of height
Time Frame: Change from Baseline at 3 months
Height will be measured using a height ruler, expressed in meters.
Change from Baseline at 3 months
change of weight
Time Frame: Change from Baseline at 3 months
Weight will be measured using a weighting scale, expressed in kilograms.
Change from Baseline at 3 months
change of waistline
Time Frame: Change from Baseline at 3 months
Waistline will be measured using a flexible rule, expressed in centimeters.
Change from Baseline at 3 months
change of blood pressure
Time Frame: Change from Baseline at 3 months
Blood pressure will be measured using a sphygmomanometer, expressed in millimeter of mercury.
Change from Baseline at 3 months
change of gait data
Time Frame: Change from Baseline at 3 months
Acquire gait data in a quiet, well-lit room. Specify the walking area to guide the participants to complete the walking cycle.
Change from Baseline at 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Qing Fan, Shanghai Mental Health Center
  • Study Chair: Xiaodan Liu, School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 16, 2022

Primary Completion (Anticipated)

June 1, 2023

Study Completion (Anticipated)

June 1, 2023

Study Registration Dates

First Submitted

February 22, 2022

First Submitted That Met QC Criteria

March 26, 2022

First Posted (Actual)

April 5, 2022

Study Record Updates

Last Update Posted (Actual)

October 26, 2022

Last Update Submitted That Met QC Criteria

October 25, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • YSF2021-59

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on daily rehabilitation interventions

Subscribe